Ute Petzinger

  • Citations Per Year
Learn More
AIM SWING was a prospective, observational study conducted in nine European countries primarily to assess direct treatment costs when switching from short-acting human insulins to rapid-acting insulin analogues (H-A) or vice versa (A-H) in patients with type 2 diabetes. METHODS Data were collected at a baseline visit (time of switch) and at approximately(More)
  • 1